庞桦进 - Nanfang Hospital, Southern Medical University

基本信息

浏览量：29

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 46 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Noncanonical Regulation of HOIL-1 on Cancer Stemness and Sorafenib Resistance Identifies Pixantrone As a Novel Therapeutic Agent for HCC

Peng Chen,Zheyu Dong,Wei Zhu,Junling Chen, Yuxin Zhou,Qiuyue Ye,Xinxin Liao, Yongfa Tan,Chuanjiang Li,Yuhao Wang,Huajin Pang,Chunhua Wen,Yuchuan Jiang, Xiaoqing Li,Bo Li, Aihetaimu Aimaier,Li Lin,Jian Sun,Jiajie Hou,Libo Tang,Jinlin Hou,Yongyin Li

HEPATOLOGY（2024）

引用0浏览0WOS引用

Hepatic Artery Infusion Chemotherapy Combined with Camrelizumab Plus Rivoceranib for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: a Multicenter Propensity Score-Matching Analysis

Yangyang Li,Jiandong Guo,Wendao Liu,Huajin Pang,Yipei Song, Siyi Wu, Fengtao Zhang, Dong Yan,Junwei Chen,Chao An,Chengzhi Li

HEPATOLOGY INTERNATIONALno. 4 (2024): 1286-1298

引用0浏览0WOS引用

Prognosis Prediction and Risk Stratification of Transarterial Chemoembolization or Intraarterial Chemotherapy for Unresectable Hepatocellular Carcinoma Based on Machine Learning

Wendao Liu,Ran Wei,Junwei Chen,Yangyang Li,Huajin Pang, Wentao Zhang,Chao An,Chengzhi Li

EUROPEAN RADIOLOGY (2024)

引用0浏览0WOS引用

Transarterial Chemoembolization With/without Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: a Single Center, Propensity Score Matching Real-World Study

Guosheng Yuan,Wenli Li,Mengya Zang,Rong Li,Qi Li,Xiaoyun Hu,Qi Zhang,Wei Huang,Jian Ruan,Huajin Pang,Jinzhang Chen

DISCOVER ONCOLOGY（2024）

引用0浏览0WOS引用

Efficiency and Safety of Hepatic Arterial Infusion Chemotherapy (HAIC) Combined with Anti‐pd1 Therapy Versus HAIC Monotherapy for Advanced Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis

Yangyang Li,Wendao Liu,Junwei Chen, Yongxin Chen,Jiandong Guo,Huajin Pang, Wentao Zhang,Chao An,Chengzhi Li

CANCER MEDICINEno. 1 (2024)

引用0浏览0WOS引用

Camrelizumab Combined with Lenvatinib and RALOX-HAIC for Hepatocellular Carcinoma (HCC) in BCLC Stage B and C: A Prospective, Single-Arm, Phase II Trial (cal Era Study)

Jinzhang Chen, Mengya Zang,Huajin Pang,Chuanjiang Li, Jianbo Zhao,Yabing Guo,Jinlin Hou

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用1浏览0引用

Ozonated Water Inhibits Hepatocellular Carcinoma Invasion and Metastasis by Regulating the HMGB1/NF-κB/STAT3 Signaling Pathway

Shuiying Tang,Bihong Xu,Huajin Pang,Lijun Xiao,Quelin Mei,Xiaofeng He

JOURNAL OF HEPATOCELLULAR CARCINOMA (2023): 203-215

引用0浏览0WOS引用

Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study

Mengya Zang,Xiaoyun Hu,Guosheng Yuan,Rong Li,Wenli Li,Huajin Pang,Qi Li,Jinzhang Chen

INTERNATIONAL IMMUNOPHARMACOLOGYno. Pt A (2023): 111019-111019

引用0浏览0WOS引用

RBCK1 promotes cancer stemness and sorafenib resistance by restoring Numb/Notch1 axis independently of its ubiquitin ligase activity in hepatocellular carcinoma

Peng Chen,Zheyu Dong,Jian Ruan,Junling Chen,Yuxin Zhou,Xinxin Liao, Yongfa Tan,Chuanjiang Li,Yuhao Wang,Huajin Pang,Chunhua Wen,Yuchuan Jiang, Xiaoqing Li,Bo Li, Aihetaimu Aimaier,Li Lin,Jian Sun,Jiajie Hou,Libo Tang,Jinlin Hou,Yongyin Li

Journal of Hepatology (2023): S543-S544

引用0浏览0引用

Tumor-feeding artery diameter reduction is associated with improved short-term effect of hepatic arterial infusion chemotherapy plus lenvatinib treatment

De-Di Wu,Xiao-Feng He,Chen Tian, Peng Peng,Chuan-Li Chen,Xue-Han Liu,Hua-Jin Pang

WORLD JOURNAL OF GASTROENTEROLOGY（2022）

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Huajin Pang(庞桦进)

论文共 46 篇作者统计合作学者相似作者